• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,520.87 233.75
(0.47%)
Dow Jones
6,986.78 44.32
(0.64%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,123.15 78.46
(0.78%)
Forex
USD-INR
89.91 -0.02
(-0.02%)
EUR-INR
104.90 -0.20
(-0.19%)
GBP-INR
120.86 -0.43
(-0.35%)
JPY-INR
0.57 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Asian Granito India Ltd
Industry :  Ceramics - Tiles / Sanitaryware
BSE Code
ISIN Demat
Book Value()
532888
INE022I01019
62.6521589
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASIANTILES
63.51
1679.04
EPS(TTM)
Face Value()
Div & Yield %
1.14
10
0
 

Natco Pharma concludes USFDA inspection of its API unit in Chennai
Nov 21,2025

Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Active Pharmaceutical Ingredients (API) Unit. The inspection was conducted from 17 - 21 November 2025.

On conclusion of the inspection, the Company received seven observations in the Form-483. The Company believes that the observations are procedural in nature. The Company is confident to address these observations comprehensively.